Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JH5S | ISIN: FR0013326246 | Ticker-Symbol: 1BR1
Tradegate
24.01.25
20:40 Uhr
76,94 Euro
+0,24
+0,31 %
1-Jahres-Chart
UNIBAIL-RODAMCO-WESTFIELD SE Chart 1 Jahr
5-Tage-Chart
UNIBAIL-RODAMCO-WESTFIELD SE 5-Tage-Chart
RealtimeGeldBriefZeit
76,5876,8213:04
76,5076,8824.01.
GlobeNewswire (Europe)
418 Leser
Artikel bewerten:
(2)

Unibail-Rodamco-Westfield SE: Meeting of the Supervisory Board of Unibail-Rodamco-Westfield held on October 4, 2024

Finanznachrichten News

Paris, October 4, 2024

Press release

Meeting of the Supervisory Board of Unibail-Rodamco-Westfield held on October 4, 2024

The Supervisory Board (SB) of Unibail-Rodamco-Westfield (URW) met today.

Further to his appointment at the Board of Directors of ByteDance, TikTok's parent company, Mr Xavier Niel has informed the SB of his decision to resign as member of the SB effective as at October 4, 2024. On behalf of the SB and the Management Board, the SB Chairman warmly thanked Mr Xavier Niel for his tremendous contribution to URW and his full trust and support to the Group's strategy and management as a major shareholder of URW.

Mr Xavier Niel has suggested the cooptation of Mr Michael Boukobza for the remainder of his term of office as a member of the SB. "I am convinced that Michael, whom I have been working with for 25 years, with his expertise and various experiences, will make a valuable contribution to the SB. His leadership and experience will maintain the strength of the SB's collective skills. This proposal reasserts my long-term commitment towards URW".

The SB, upon the recommendation of its Governance, Nomination and Remuneration Committee (GNRC), has decided to coopt Mr Michael Boukobza as non-independent member of the SB and to appoint him as member of the GNRC, as of today.

Mr Boukobza, 46, French national, graduated from ESCP and Paris Dauphine (France). He started his career in merger & acquisition and has 25 years of expertise in entrepreneurship and cost optimization mainly in telecommunications, innovation and digital development as well as the press industry. He brings to the SB strong knowledge in - amongst others - finance, ESG, Digital/E-commerce, with also a recognized international and M&A experience.

The cooptation of Mr Boukobza will be submitted for ratification by the next annual Shareholders' Meeting of URW.

For more information, please contact:

Investor Relations
Meriem Delfi
+33 7 63 45 59 77
investor.relations@urw.com

Gonzague Montigny
+33 6 10 95 85 84
investor.relations@urw.com

Media Relations
UK/Global:
Cornelia Schnepf - FinElk
+44 7387 108 998
Cornelia.Schnepf@finelk.eu

France:
Etienne Dubanchet - PLEAD
+33 6 62 70 09 43
Etienne.Dubanchet@plead.fr

About Unibail-Rodamco-Westfield

Unibail-Rodamco-Westfield is an owner, developer and operator of sustainable, high-quality real estate assets in the most dynamic cities in Europe and the United States.

The Group operates 71 shopping centres in 12 countries, including 39 which carry the iconic Westfield brand. These centres attract over 900 million visits annually and provide a unique platform for retailers and brands to connect with consumers. URW also has a portfolio of high-quality offices, 10 convention and exhibition venues in Paris, and a €2.9 Bn development pipeline of mainly mixed-use assets. Its €50 Bn portfolio is 86% in retail, 6% in offices, 5% in convention and exhibition venues, and 2% in services (as at June 30, 2024).

URW is a committed partner to major cities on urban regeneration projects, through both mixed-use development and the retrofitting of buildings to industry-leading sustainability standards. These commitments are enhanced by the Group's Better Places plan, which strives to make a positive environmental, social and economic impact on the cities and communities where URW operates.

URW's stapled shares are listed on Euronext Paris (Ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from a BBB+ rating from Standard & Poor's and from a Baa2 rating from Moody's.

For more information, please visit www.urw.com


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.